40890 Grand River Ave, Novi, MI 48375Novi, MI(248) 987-6182Fax: (248) 987-4963
Clear Choice Pharmacy — Your Affordable Care Pharmacy
Medical weight loss overviewGLP-1 weight managementSemaglutide kitsTirzepatide kitsWeight loss medicationsWeight loss FAQ
Low cost prescriptionsSee how much your medications costHow pricing worksCompounding pharmacy
All servicesLow cost prescription drugsCompoundingSpecialty pharmacyMen's health (ED & TRT)Mobile IV therapyAbout usContactLearn guides
GLP-1 education

GLP-1 Weight Management in Michigan

How glucagon-like peptide-1 therapies fit into provider-guided care.

GLP-1 receptor agonists are prescription medications used under clinician supervision for weight management and related metabolic care. Clear Choice Pharmacy compounds patient-specific Semaglutide and Tirzepatide after a licensed clinician reviews your intake.

View medical weight loss programCompare medications
Educational overview · Not medical advice · Michigan pharmacy fulfillment

Basics

What are GLP-1 medications?

GLP-1 receptor agonists mimic a hormone involved in appetite regulation and glucose control. They are not over-the-counter supplements and require a prescription.

When clinically appropriate, GLP-1 therapies may help patients feel fuller sooner and support reduced calorie intake as part of a broader plan that includes nutrition, activity, and follow-up. Individual responses vary, and these medications are not appropriate for everyone.

Brand-name products patients often research include Ozempic and Wegovy (Semaglutide) and Mounjaro and Zepbound (Tirzepatide). Clear Choice Pharmacy compounds Semaglutide and Tirzepatide pursuant to patient-specific prescriptions. Compounded medications are not the same as FDA-approved brand products.

Options

Semaglutide and Tirzepatide

Both are once-weekly injectable options used under clinician supervision. Your provider recommends the pathway that fits your clinical profile.

✓

Semaglutide

GLP-1 receptor agonist pathway used in provider-guided weight management kits at Clear Choice Pharmacy.

✓

Tirzepatide

Dual GLP-1/GIP pathway option when a clinician determines it is appropriate.

✓

Evaluation first

Intake, photo ID, and clinician review occur before any compounding or charge capture.

✓

Pharmacy role

Clear Choice compounds and fulfills approved kits for qualifying Michigan patients from Novi.

Semaglutide kitsTirzepatide kits

Expectations

What to expect

Starting a GLP-1 medication involves clinical screening, titration, and monitoring for side effects—especially gastrointestinal symptoms during dose increases.

Your clinician sets the starting dose and titration plan. Many patients experience nausea, fullness, or other GI effects early on; report concerning symptoms promptly. Serious risks are uncommon but require medical evaluation if they occur.

For program steps, pricing, and eligibility, return to the medical weight loss program page or read the weight loss FAQ.

This page is educational and does not replace advice from your licensed clinician. GLP-1 therapies require a valid prescription. Compounded medications are prepared pursuant to a patient-specific prescription. Individual results may vary.

Continue to the medical weight loss program

Review kits, pricing, and how provider-guided care works at Clear Choice Pharmacy.

Medical weight loss overviewWeight loss FAQ
Clear Choice Pharmacy — Your Affordable Care Pharmacy
40890 Grand River Ave
Novi, MI 48375
(248) 987-6182
Fax: (248) 987-4963

Michigan pharmacy focused on provider-guided medical weight management and GLP-1 care, with full-service prescriptions and compounding.

Medical Weight Loss

Medical weight loss programGLP-1 weight managementSemaglutide kitsTirzepatide kitsWeight loss medicationsWeight loss FAQWeight management guides

Pharmacy services

Low cost prescription drugsCompoundingSpecialty pharmacyMen's healthMobile IV therapyAll services

About & support

About Clear Choice PharmacyContactPatient portalPrivacy policyTermsRefund policy

© 2026 Clear Choice Pharmacy. All rights reserved.